HHLA2 and osteosarcoma: The poor prognostic value of HHLA2 was also reported in clear cell RCC, osteosarcoma and TNBC (Janakiram et al., 2015a; Koirala et al., 2016; Chen et al., 2018; Chen et al., 2019).